Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies

被引：2
|
作者：
Niscola, Pasquale [1 ]
Gianfelici, Valentina [1 ]
Catalano, Gianfranco [2 ]
Giovannini, Marco [1 ]
Mazzone, Carla [1 ]
Noguera, Nelida Ines [2 ,3 ]
de Fabritiis, Paolo [1 ,2 ]
机构：
[1] S Eugenio Hosp ASL Roma 2, Hematol Unit, I-00144 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy
[3] IRCCS, St Lucia Fdn, Neurooncoemtol Units, I-00143 Rome, Italy
来源：
CURRENT ONCOLOGY | 2024年 / 31卷 / 11期
关键词：
genomic profiling; targeted therapies; hypomethylating agents; venetoclax-based combinations; intensive chemotherapy; transplantation clinical trials; supportive care; quality of life; HEALTH-ORGANIZATION CLASSIFICATION; MEASURABLE RESIDUAL DISEASE; VENETOCLAX-BASED THERAPY; GILTERITINIB; AZACITIDINE; METABOLISM; CHEMOTHERAPY; NEOPLASMS; EVOLUTION; CRITERIA;
D O I：
10.3390/curroncol31110490
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Acute myeloid leukemia (AML) is a heterogeneous blood-related neoplasm that predominantly afflicts older adults with a poor prognosis due to their physical condition and the presence of medical accompanying comorbidities, adverse biological disease features, and suitability for induction intensive chemotherapy and allogenic stem cells transplantation. Recent research into the molecular and biological factors contributing to disease development and progression has led to significant advancements in treatment approaches for older patients with AML. This review article discusses the latest biological and therapeutic developments that are transforming the management of AML in older adults.
引用
收藏
页码：6632 / 6658
页数：27
相关论文
共 50 条
  • [21] Gene mutations and molecularly targeted therapies in acute myeloid leukemia
    Hatzimichael, Eleftheria
    Georgiou, Georgios
    Benetatos, Leonidas
    Briasoulis, Evangelos
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2013, 3 (01): : 29 - 51
  • [22] Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid Leukemia
    Ahmadmehrabi, Khashayar
    Haque, Ali R.
    Aleem, Ahmed
    Griffiths, Elizabeth A.
    Roloff, Gregory W.
    CANCERS, 2021, 13 (18)
  • [23] Update on Small Molecule Targeted Therapies for Acute Myeloid Leukemia
    Wang, Jiasheng
    Tomlinson, Benjamin
    Lazarus, Hillard M.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2023, 24 (07) : 770 - 801
  • [24] Update on Small Molecule Targeted Therapies for Acute Myeloid Leukemia
    Jiasheng Wang
    Benjamin Tomlinson
    Hillard M. Lazarus
    Current Treatment Options in Oncology, 2023, 24 : 770 - 801
  • [25] Older patients with acute myeloid leukemia
    Yee, Karen W. L.
    Keating, Armand
    EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (06) : 755 - 774
  • [26] New Treatment Options for Older Patients with Acute Myeloid Leukemia
    Kapil Saxena
    Marina Konopleva
    Current Treatment Options in Oncology, 2021, 22
  • [27] New insights in the management of elderly patients with acute myeloid leukemia
    Dombret, Herve
    Raffoux, Emmanuel
    Gardin, Claude
    CURRENT OPINION IN ONCOLOGY, 2009, 21 (06) : 589 - 593
  • [28] Treatment of older patients with acute myeloid leukemia - New agents
    Burnett, AK
    Mohite, U
    SEMINARS IN HEMATOLOGY, 2006, 43 (02) : 96 - 106
  • [29] New Treatment Options for Older Patients with Acute Myeloid Leukemia
    Saxena, Kapil
    Konopleva, Marina
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (05)
  • [30] Molecularly targeted therapies for pediatric acute myeloid leukemia: Progress to date
    Brown P.
    Smith F.
    Pediatric Drugs, 2008, 10 (2) : 85 - 92
12345